WCPS: Analysis of Metal Impurities in Pharmaceutical Ingredients in Preparation for the New USP Methods
Posters
| 2011 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products
Posters
| 2012 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Elemental Impurities in Aspirin: USP <232>/<233> and ICH Q3D Methods Using ICP-OES
Applications
| 2021 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>
Applications
| 2015 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Prev
1
Next
Related content
Wiley released AntiBase Library 2024 – the Latest Version of Wiley Identifier of Natural Products
Su, 28.4.2024
LabRulez
Scientists continue to push the boundaries of imaging techniques and reveal the mysterious world of molecules
Th, 25.4.2024
Ústav organické chemie a biochemie AV ČR
Preventing early-onset colorectal cancers aim of $25 million award